
Atopic Dermatitis Market Forecast Report 2025-2034 FDA Approval Of Tralokinumab-Ldrm Stimulates Treatment Advances
(MENAFN- GlobeNewsWire - Nasdaq) The atopic dermatitis market, valued at USD 9.33 billion in 2024, is projected to grow at a CAGR of 15.10%, reaching USD 38.07 billion by 2034. Key drivers include increasing prevalence, FDA approvals like LEO Pharma's …